Comparison of a new colorimetric assay with the NCCLS broth microdilution method (M-27A) for antifungal drug MIC determination

Journal of Clinical Microbiology

Volumn 38, Issue 6, 2000, Pages 2334-2338

  Li, R K ^a,b   Elie, C M ^a   Clayton, G E ^a   Ciblak, M A ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE;

ANTIBIOTIC SENSITIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; COLORIMETRY; GLUCOSE UTILIZATION; INTERMETHOD COMPARISON; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; ISSATCHENKIA ORIENTALIS;

EID: 0034043096     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/.38.6.2334-2338.2000     Document Type: Article

References (11)

1. Espinel-Ingroff, A., and M. A. Pfaller. 1995. Antifungal agents and susceptibility testing, p. 1405-1414. In P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 6th ed. American Society for Microbiology, Washington, D.C.
2. Fromtling, R. A., J. N. Galgiani, M. A. Pfaller, A. Espinel-Ingroff, K. F. Bartizal, M. S. Bartlett, B. A. Body, C. Frey, G. Hall, G. D. Roberts, F. B. Nolte, F. C. Odds, M. G. Rinaldi, A. M. Sugar, and K. Villareal. 1993. Multicenter evaluation of a broth macrodilution antifungal susceptibility test for yeasts. Antimicrob. Agents Chemother. 37:39-45.
3. Galgiani, J. N., J. Reiser, C. Brass, A. Espinel-Ingroff, M. A. Gordon, and T. M. Kerkering. 1987. Comparison of relative susceptibility of Candida species to three antifungal agents as determined by unstandardized methods. Antimicrob. Agents Chemother. 31:1343-1347.
4. Graybill, J. R., E. Montalbo, W. R. Kirkpatrick, M. F. Luther, S. G. Revankar, and T. F. Patterson. 1998. Fluconazole versus Candida albicans: a complex relationship. Antimicrob. Agents Chemother. 42:2938-2942.
5. National Committee for Clinical Laboratory Standards. 1997. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard. Document M-27A. National Committee for Clinical Laboratory Standards, Wayne, Pa.
6. Perfect, J. R., and W. A. Schell. 1996. The new fungal opportunists are coming. Clin. Infect. Dis. 22:S112-S118.
7. Pfaller, M. A., R. N. Jones, S. A. Messer, M. B. Edmond, and R. P. Wenzel. 1998. National surveillance of nosocomial blood stream infection due to species of Candida other than Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE program. Diagn. Microbiol. Infect. Dis. 30:121-129.
8. Powles, R. L., and J. Mehta. 1996. Systemic fungal infections: major problems in cancer patients. Indian J. Cancer 31:180-184.
9. Rex, J. H., M. A. Pfaller, J. N. Galgiani, M. S. Bartlett, A. Espinel-Ingroff, M. A. Ghannoum, M. Lancaster, F. C. Odds, M. G. Rinaldi, T. J. Walsh, and A. L. Barry. 1997. Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and Candida infections. Clin. Infect. Dis. 24:235-247.
10. Riesselman, M. H., K. C. Hazen, and J. E. Cutler. 2000. Determination of antifungal MICs by a rapid susceptibility assay. J. Clin. Microbiol. 38:333-340.
11. Sheehan, D. J., A. Espinel-Ingrof, L. S. Moore, and C. D. Webb. 1993. Antifungal susceptibility testing of yeasts: a brief overview. Clin. Infect. Dis. 17(Suppl. 2):S494-S500.